Neuromorphic computing company BrainChip Holdings (ASX:BRN), reports the company ended the December quarter with US$7.5 million in cash.
Sales engagements in the quarter included 26 active or pending trials with end-users and original equipment manufacturers (OEMs).
The Company has strengthened its sales and reseller presence in both Europe and North America.
Also during the December 2018 quarter it strengthened its property protection with the filing of an omnibus provisional US patent application with the United States Patent and Trademark Office (USPTO).
Shares in BrainChip Holdings (ASX:BRN) closed 2.15 per cent lower to $0.09.